Topaz Jones Featuring Hodgy Beats “Lap Of Luxury” Topaz Jones Featuring Hodgy Beats “Lap Of Luxury” A day before the release of his debut project The Honeymoon Suite, Topaz Jones drops off ...

Oct. 2, 2024 — Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in ... Cannabinoid CBG Reduces ...

She’s all lazy… and boring.” This image of Sarah, reduced to a mere shell of her former self, was the centerpiece of an anti-marijuana campaign that sought to convey a powerful message ...

Left Brain Stars in Converse and Babylon’s Collabrative Lookbook Left Brain Stars in Converse and Babylon’s Collabrative Lookbook Left Brain is the star of the ...

It's time to end the War on Marijuana. The aggressive enforcement of marijuana possession laws needlessly ensnares hundreds of thousands of people into the criminal justice system and wastes billions ...

Election Day is Tuesday and in four states, voters will have the opportunity to cast their thoughts on the future of marijuana legislation. Here's what to know about marijuana legislation and what ...

These are Tyler, the Creator’s albums, ranked from worst to best. Bastard Released: 2009 Features: Casey Veggies, Hodgy Beats, Domo Genesis, Earl Sweatshirt, brandUn DeShay, Mike G, Jasper ...

Readers respond to a front-page article about the growing use of marijuana after legalization. To the Editor: Re “Unexpected Problem in the Rise of Marijuana” (front page, Oct. 5): As we ...

Opinions expressed by Forbes Contributors are their own. A.J. Herrington is freelance writer covering weed news and culture. Former president and Republican presidential nominee Donald Trump on ...

For decades, state and federal lawmakers and U.S. residents have navigated the ever-evolving policies that determine who can legally use marijuana and in what form it may legally be consumed.

Marijuana stocks have given cannabis investors nothing but false starts over the past few years. The industry has struggled with a plethora of issues, including inflation, overproduction, lack of ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. Vice President ...